Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for Astellas
Company Monitoring Page for Astellas
latest headlines for company on cafepharma
Pfizer's Xtandi Gets FDA Nod for Expanded Patient Population
Yahoo/Zacks.com
Mon, 07/16/18 - 09:40 am
Tags:
Pfizer
,
FDA
,
Astellas
,
Xtandi
,
prostate cancer
With the ink on their $25M Astellas deal still drying, Aquinox shares get blasted on PhIII failure
Endpoints
Wed, 06/27/18 - 10:21 am
Tags:
Aquinox Pharmaceuticals
,
Astellas
,
rosiptor
,
Asia
,
clinical trials
,
Interstitial Cystitis
After a crushing PhIII failure, Cytokinetics says its next-gen muscle drug is lining up well in PhII — but big challenges loom
Endpoints
Mon, 06/18/18 - 10:00 am
Tags:
Cytokinetics
,
clinical trials
,
reldesemtiv
,
Tirasemtiv
,
spinal muscular atrophy
,
Astellas
Astellas shedding 600-plus jobs as CEO shakes up R&D and sales ops in restructuring
Endpoints
Wed, 05/23/18 - 12:02 pm
Tags:
Astellas
,
layoffs
,
R&D
,
sales
,
restructuring
,
Kenji Yasukawa
Astellas to pay Aquinox $25M upfront for regional rights to phase 3 inflammatory pain drug
Fierce Biotech
Thu, 05/10/18 - 09:32 am
Tags:
Astellas
,
Aquinox Pharmaceuticals
,
SHIP1 activator
,
Japan
,
Asia
,
rosiptor
Pfizer, Astellas peg Xtandi expansion on PROSPER data
Biopharma Dive
Mon, 02/5/18 - 07:09 pm
Tags:
Pfizer
,
Astellas
,
Xtandi
,
prostate cancer
Astellas, Vical's CMV vaccine comes up short in Phase 3
Biopharma Dive
Tue, 01/23/18 - 02:49 pm
Tags:
Astellas
,
Vical
,
CMV
,
cytomegalovirus
,
vaccines
,
clinical trials
,
ASP0113
Patent setback could sting J&J prostate cancer franchise
Biopharma Dive
Fri, 01/19/18 - 11:11 am
Tags:
patents
,
JNJ
,
prostate cancer
,
Zytiga
,
Xtandi
,
Astellas
Astellas joins crowd of pharmas under investigation for copay charity donations
Fierce Pharma
Thu, 11/16/17 - 07:22 pm
Tags:
Astellas
,
charity
Astellas innovation contest's second year yields bumper crop of creative cancer solutions
Fierce Pharma
Mon, 10/30/17 - 11:04 am
Tags:
Astellas
,
innovation
,
oncology
Astellas turns to 'corporate branding 2.0'
Medical Marketing and Media
Sat, 10/7/17 - 11:03 am
Tags:
Astellas
,
corporate branding
New PhIII data in hand, Pfizer, Astellas hustle ahead in bid to expand US market for Xtandi
Endpoints
Thu, 09/14/17 - 10:27 am
Tags:
Pfizer
,
Astellas
,
clinical trials
,
Xtandi
,
prostate cancer
Astellas is shuttering Agensys, axing 220 jobs and moving away from ADC tech
Endpoints
Thu, 07/27/17 - 07:36 pm
Tags:
Astellas
,
Agensys
,
layoffs
,
antibody-drug conjugate
Astellas UK narrowly dodges expulsion after more trouble with Britain's pharma cops
Fierce Pharma
Sun, 06/25/17 - 06:25 pm
Tags:
Astellas
,
UK
Pfizer builds out anti-infective reach with Basilea deal
BioPharma Dive
Fri, 06/16/17 - 09:48 pm
Tags:
Pfizer
,
Basilea
,
anti-fungal
,
Cresemba
,
Astellas
Astellas reprimanded by U.K. drug regulator
Medical Marketing and Media
Sat, 06/10/17 - 12:12 pm
Tags:
Astellas
,
UK
Astellas completes 800 million euro biotech acquisition of Ogeda
Pharma Times
Sat, 05/20/17 - 01:20 pm
Tags:
Ogeda
,
Astellas
,
M&A
Astellas, Pfizer scrap a PhIII breast cancer study using Xtandi; New $30M fund will back Israeli biotech startups
Endpoints
Sat, 05/20/17 - 12:50 pm
Tags:
Astellas
,
Pfizer
,
breast cancer
,
clinical trials
,
Xtandi
,
Israel
,
biotech
Astellas scraps NSCLC program after look at phase 3 data
Fierce Biotech
Fri, 05/12/17 - 11:47 am
Tags:
Astellas
,
non-small cell lung cancer
,
clinical trials
,
ASP8273
Astellas swoops in on a mid-stage drug for hot flashes in $860M biotech buyout deal
Endpoints
Mon, 04/3/17 - 09:23 am
Tags:
Astellas
,
hot flashes
,
M&A
,
Ogeda
Pages
« first
‹ previous
…
7
8
9
10
11
12
13
14
15
…
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
a dog would most likely chase a: cat, rock, house
*
Fill in the blank.